Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)

Author： Gralla Richard  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.17, Iss.3, 2009-03, pp. : 307-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant and adjuvant therapy of non-small cell lung cancer

By Rajdev L.   Keller S.M.  

Surgical Oncology, Vol. 11, Iss. 4, 2002-12 ,pp. : 243-253

Elsevier

Access to resources Recommend Favorite

Treatment of Patients with Advanced Non-Small Cell Lung Cancer: Importance of Symptom Management and Attention to Quality of Life or Clinical Benefit

By Christophe A. Dooms   Johan F. Vansteenkiste  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 281-290

Adis International

Access to resources Recommend Favorite

Effect of chemotherapy on quality of life in patients with non-small cell lung cancer

By Mannion Eileen   Gilmartin J.   Donnellan Paul   Keane Maccon   Waldron Dympna  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1417-1428

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small-cell lung cancer: a review of prospective studies

By Robinson Cliff   Stephans Kevin  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 47-60

Future Medicine

Access to resources Recommend Favorite

Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer

By Simon George R   Begum Mubeena   Bepler Gerold  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 51-59

Future Medicine

Access to resources Recommend Favorite